Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

nnarum Aug. 18 at 7:28 PM

$UPS Loaded up on the boomer stocks today. Cash flow in market pull backs is like oxygen. Happy with the future dividends. $MO $CMCSA $T $PFE

0 · Reply

ProTraderColin Aug. 18 at 7:25 PM

$PFE do it! 🚀

0 · Reply

Samishere Aug. 18 at 6:57 PM

$BNTX $MRK $MRNA $PFE

1 · Reply

Tbry9 Aug. 18 at 6:50 PM

$PFE Are you guys looking for growth out of pfe or mainly the dividend?

1 · Reply

Micheal_Pothead Aug. 18 at 6:38 PM

$PFE tf is this price action

0 · Reply

Ed_Ng Aug. 18 at 5:28 PM

$PFE nice cup and handle in weekly chart

0 · Reply

StageAnalysis Aug. 18 at 4:18 PM

Pharmaceuticals industry group is one of the strongest parts of the market currently Largest stocks in the group by weighting: $LLY, $JNJ, $MRK, $PFE, BMY, NVO, AZN, ZTS, NVS, AXSM, GSK, JAZZ, TEVA, RPRX, VTRS, SNY, ELAN, LQDA, DFTX, CORT, RHHBY, ELVN, TARS, NKTR, TAK, AMLX, SUPN, TRVI, RDY, PRGO, AMRX, OGN, PBH, HRMY, HROW, ANIP, OCUL, BHC, SEPN, INVA, MAZE, XERS, RAPP, LBRX, PAHC, CHGCY, GTBIF, MKKGY, TLX, HCM

1 · Reply

puckfan Aug. 18 at 3:53 PM

$TSM So we’re not doing chips no more? Good to know. Guess it’s back to watching $PFE move a penny a day.

2 · Reply

CapitalMonk Aug. 18 at 3:25 PM

$PFE Price: $27.20 (+1.53%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.36% RSI: 73.6 | Momentum: Moderate Volume: -66.5% vs avg Volatility: 1.14% Support: $24.23 | Resistance: $27.39 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

zustrelaax Aug. 18 at 3:15 PM

$PFE waiting on the catalyst / news to move it beyond 30

0 · Reply

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

2026-08-14T18:45:04.000Z - 4 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock

Aug 14, 2026, 1:45 PM EDT - 4 days ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 11:46 AM EDT - 4 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:11 AM EDT - 4 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

2026-08-14T13:47:35.000Z - 4 days ago

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

VALN

Aug 14, 2026, 1:00 AM EDT - 4 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

2026-08-07T11:40:49.000Z - 11 days ago

Pfizer price target lowered to $31 from $35 at Guggenheim

2026-08-06T13:09:00.000Z - 12 days ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-05T10:45:23.000Z - 13 days ago

Pfizer price target raised to $27 from $26 at BofA

Aug 4, 2026, 10:00 AM EDT - 14 days ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 14 days ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 14 days ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 14 days ago

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 7:24 AM EDT - 14 days ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 14 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 14 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Aug 4, 2026, 6:52 AM EDT - 14 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:45 AM EDT - 14 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Jul 30, 2026, 7:48 AM EDT - 19 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 6:45 AM EDT - 19 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 29, 2026, 4:30 PM EDT - 20 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 27 days ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 27 days ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 27 days ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 4 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 5 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 6 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 7 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 7 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 7 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 7 weeks ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 7 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 2 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 2 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

nnarum Aug. 18 at 7:28 PM

$UPS Loaded up on the boomer stocks today. Cash flow in market pull backs is like oxygen. Happy with the future dividends. $MO $CMCSA $T $PFE

0 · Reply

ProTraderColin Aug. 18 at 7:25 PM

$PFE do it! 🚀

0 · Reply

Samishere Aug. 18 at 6:57 PM

$BNTX $MRK $MRNA $PFE

1 · Reply

Tbry9 Aug. 18 at 6:50 PM

$PFE Are you guys looking for growth out of pfe or mainly the dividend?

1 · Reply

Micheal_Pothead Aug. 18 at 6:38 PM

$PFE tf is this price action

0 · Reply

Ed_Ng Aug. 18 at 5:28 PM

$PFE nice cup and handle in weekly chart

0 · Reply

StageAnalysis Aug. 18 at 4:18 PM

1 · Reply

puckfan Aug. 18 at 3:53 PM

$TSM So we’re not doing chips no more? Good to know. Guess it’s back to watching $PFE move a penny a day.

2 · Reply

CapitalMonk Aug. 18 at 3:25 PM

0 · Reply

zustrelaax Aug. 18 at 3:15 PM

$PFE waiting on the catalyst / news to move it beyond 30

0 · Reply

justAtool Aug. 18 at 3:07 PM

$PFE

1 · Reply

INEEDMONEY87 Aug. 18 at 3:07 PM

$PFE he bough 22 shares....he gona by potheads 27.5 calls next?

1 · Reply

Willieberich Aug. 18 at 2:51 PM

$PFE 29 is coming in a few months

0 · Reply

BWinner Aug. 18 at 2:40 PM

$PFE Give me $28!!!!

0 · Reply

AxieVertex Aug. 18 at 2:38 PM

$PFE The addition of ISO-7 rooms positions RMTG for much larger commercial deals that require certified manufacturing standards they are leveling up their facility and the Q2 results are going to be the first glimpse of what that level up looks like financially

0 · Reply

Micheal_Pothead Aug. 18 at 2:38 PM

$PFE daily candle today is currently cursed… I don’t like this

2 · Reply

Micheal_Pothead Aug. 18 at 2:31 PM

$PFE why did I genuinely believe we would touch 27.50 today?

0 · Reply